Schrödinger (SDGR) Revenue & Revenue Breakdown


OverviewForecastOwnershipFinancialsChartTranscripts

Schrödinger Revenue Highlights


Latest Revenue (Y)

$216.67M

Latest Revenue (Q)

$47.33M

Main Segment (Y)

Drug Discovery Contribution

Main Geography (Y)

UNITED STATES

Schrödinger Revenue by Period


Schrödinger Revenue by Year

DateRevenueChange
2023-12-31$216.67M19.73%
2022-12-31$180.96M31.19%
2021-12-31$137.93M27.60%
2020-12-31$108.09M26.36%
2019-12-31$85.54M28.37%
2018-12-31$66.64M19.65%
2017-12-31$55.69M-

Schrödinger generated $216.67M in revenue during NA 2023, up 19.73% compared to the previous quarter, and up 325.13% compared to the same period a year ago.

Schrödinger Revenue by Quarter

DateRevenueChange
2024-06-30$47.33M29.33%
2024-03-31$36.60M-50.63%
2023-12-31$74.13M74.13%
2023-09-30$42.57M20.97%
2023-06-30$35.19M-45.68%
2023-03-31$64.78M13.97%
2022-12-31$56.84M53.71%
2022-09-30$36.98M-3.87%
2022-06-30$38.47M-20.95%
2022-03-31$48.66M5.40%
2021-12-31$46.17M54.67%
2021-09-30$29.85M0.22%
2021-06-30$29.78M-7.29%
2021-03-31$32.13M-2.74%
2020-12-31$33.03M28.05%
2020-09-30$25.80M11.71%
2020-06-30$23.09M-11.78%
2020-03-31$26.17M1.32%
2019-12-31$25.83M29.42%
2019-09-30$19.96M5.00%
2019-06-30$19.01M-8.35%
2019-03-31$20.74M18.68%
2018-12-31$17.48M34.51%
2018-09-30$12.99M-

Schrödinger generated $47.33M in revenue during Q2 2024, up 29.33% compared to the previous quarter, and up 73.07% compared to the same period a year ago.

Schrödinger Revenue Breakdown


Schrödinger Revenue Breakdown by Product

Annual Revenue by Product

Product/ServiceDec 22Dec 21Dec 20
Drug Discovery Contribution$1.95M--
Hosted Software-$11.08M$9.19M
Software Contribution-$1.00M-
Revenue From Contract With Customer Before Software Contribution-$112.24M-
Professional Services-$9.27M$9.56M
On Premise Software-$74.60M$58.31M
Software Products And Services-$113.24M$92.53M
Maintenance-$17.29M$14.46M
Contribution--$1.00M
Revenue From Contract With Customer Before Contribution--$91.53M

Schrödinger's latest annual revenue breakdown by segment (product or service), as of Dec 22: Drug Discovery Contribution (100.00%).

Quarterly Revenue by Product

Product/ServiceJun 24Mar 24Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20Jun 20Mar 20
Software Products And Services$35.40M$33.41M$29.58M$32.21M$8.10M$24.67M$30.01M$33.08M$38.56M$24.28M$24.05M$26.34M$24.96M$22.86M$20.90M$23.81M-
Revenue From Contract With Customer Before Contribution$35.40M$33.41M$27.10M$24.67M$29.01M$24.28M$23.05M$24.96M$22.86M$19.90M-------
Hosted Software$8.09M$7.18M$5.46M$4.45M$4.13M$3.91M$3.60M$3.25M$3.09M$2.68M$2.70M$2.60M$2.37M$2.37M$2.31M$2.13M-
Contribution--$1.80M-$1.00M-$1.00M--$1.00M-------
Maintenance$5.84M$5.89M$5.75M$5.75M$5.25M$5.06M$4.95M$4.73M$4.61M$4.40M$4.18M$4.11M$3.84M$3.54M$3.55M$3.54M-
On Premise Software$18.76M$17.62M$13.81M$19.94M$33.63M$12.58M$16.59M$21.69M$27.30M$15.50M$14.45M$17.36M$16.54M$15.06M$11.11M$15.60M-
Professional Services$2.72M$2.73M$2.08M$2.07M$4.81M$3.11M$3.87M$3.41M$3.57M$1.70M$1.72M$2.28M$2.20M$1.89M$2.93M$2.54M-
Drug Discovery Contribution---$605.00K-------------
Drug Discovery Services Revenue From Contracts With Customers----$31.80M$11.72M$8.02M----------
Drug Discovery Services----$2.17M$1.94M$2.00M$1.35M---------
Drug Discovery----$32.57M$10.04M$12.31M$8.46M---------

Schrödinger's latest quarterly revenue breakdown by segment (product or service), as of Jun 24: Software Products And Services (33.33%), Revenue From Contract With Customer Before Contribution (33.33%), On Premise Software (17.66%), Hosted Software (7.61%), Maintenance (5.50%), and Professional Services (2.56%).

Schrödinger Revenue Breakdown by Country

Annual Revenue by Country

CountryDec 22Dec 21Dec 20
JAPAN$10.47M$8.56M$14.56M
Europe$33.05M$27.81M$24.37M
UNITED STATES$123.56M$90.40M$60.74M
Non-US$13.88M--
Non Us-$11.16M$8.43M

Schrödinger's latest annual revenue breakdown by geography, as of Dec 22: UNITED STATES (68.28%), Europe (18.26%), Non-US (7.67%), and JAPAN (5.79%).

Quarterly Revenue by Country

CountryJun 24Mar 24Sep 23Jun 23Mar 23Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20Jun 20Mar 20
EMEA$7.80M$7.20M$3.76M$4.83M------------
Non-US$121.00K$604.00K$117.00K$156.00K$3.43M$3.65M----------
UNITED STATES$30.70M$23.30M$33.13M$23.96M$50.34M$27.47M$27.10M$30.27M$31.99M$19.68M$16.91M$16.34M$17.77M$13.14M$13.49M-
APAC$8.71M$5.50M$5.57M$6.24M------------
JAPAN----$4.36M$2.00M$2.97M$1.56M$2.19M$2.91M$1.53M$6.69M$2.90M$3.00M$1.97M-
Europe----$6.65M$3.86M$5.11M$12.64M$9.45M$3.57M$4.25M$10.54M$7.88M$3.28M$4.92M$8.28M
Non Us------$3.29M$4.19M$2.53M$2.54M$2.95M$3.14M$2.12M$1.85M$2.03M$2.44M
J P---------$1.92M------
U S---------$21.82M------

Schrödinger's latest quarterly revenue breakdown by geography, as of Jun 24: UNITED STATES (64.86%), APAC (18.40%), EMEA (16.49%), and Non-US (0.26%).

Schrödinger Peer Comparison by Revenue


TickerCompanyLast Year RevenueLast Quarter Revenue
GEHCGE HealthCare$19.55B$4.86B
TDOCTeladoc Health$2.60B$640.51M
VEEVVeeva Systems$2.36B$676.18M
PGNYProgyny$1.09B$304.09M
HQYHealthEquity$999.59M$299.93M
TXG10x Genomics$618.73M$151.65M
DOCSDoximity$475.42M$126.68M
ACCDAccolade$414.29M$106.36M
CERTCertara$354.34M$93.31M
SDGRSchrödinger$216.67M$47.33M
AMWLAmerican Well--

SDGR Revenue FAQ


Schrödinger's yearly revenue for 2023 was $216.67M, representing an increase of 19.73% compared to 2022. The company's yearly revenue for 2022 was $180.96M, representing an increase of 31.19% compared to 2021. SDGR's yearly revenue for 2021 was $137.93M, representing an increase of 27.60% compared to 2020.

Schrödinger's quarterly revenue for Q2 2024 was $47.33M, a 29.33% increase from the previous quarter (Q1 2024), and a 34.51% increase year-over-year (Q2 2023). The company's quarterly revenue for Q1 2024 was $36.6M, a -50.63% decrease from the previous quarter (Q4 2023), and a -43.51% decrease year-over-year (Q1 2023). SDGR's quarterly revenue for Q4 2023 was $74.13M, a 74.13% increase from the previous quarter (Q3 2023), and a 30.40% increase year-over-year (Q4 2022).

Schrödinger's revenue growth rate for the last 3 years (2021-2023) was 57.08%, and for the last 5 years (2019-2023) was 153.28%.

Schrödinger's revenue streams in c 22 are Drug Discovery Contribution

For the fiscal year ending Dec 22, the largest source of revenue of Schrödinger was Drug Discovery Contribution. This segment made a revenue of $1.95M, representing 100.00% of the company's total revenue.